BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3696324)

  • 41. Experimental membranous glomerulonephritis in rats induced with gp 700, a glomerular protein.
    Kamata K; Sato N; Horata E; Kobayashi Y; Okubo M
    Int Immunol; 1990; 2(11):1013-20. PubMed ID: 1707302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of injecting brush border antigen on Heymann nephritis.
    Hara M; Yamamoto T; Kihara I
    Tohoku J Exp Med; 1982 Jun; 137(2):153-61. PubMed ID: 7112543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephritogenic glycoprotein. XIV. A simple isolation method of nephritogenoside.
    Shibata S; Yokoyama M
    Nephron; 1990; 55(2):152-8. PubMed ID: 2362628
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells.
    Camussi G; Salvidio G; Biesecker G; Brentjens J; Andres G
    J Immunol; 1987 Nov; 139(9):2906-14. PubMed ID: 3312408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on the pathogenic roles of antigens isolated from renal tubular cells in the classical Heymann nephritis].
    Yamagata K; Koyama A; Kobayashi M; Narita M
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1053-60. PubMed ID: 2287097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
    Kerjaschki D
    Wien Klin Wochenschr; 1985 Jul; 97(14):581-8. PubMed ID: 3901534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.
    Quigg RJ; Holers VM; Morgan BP; Sneed AE
    J Immunol; 1995 Apr; 154(7):3437-43. PubMed ID: 7534798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymocytes reacting with heterologous antibodies against GP 330 in autologous immune complex glomerulopathy (AICG) in the rat. The relation between susceptibility for AICG and anti-GP 330-binding thymocytes.
    Bagchus WM; Hoedemaeker PJ; Vos JT; Bakker WW
    Immunobiology; 1989 Oct; 179(4-5):432-44. PubMed ID: 2693345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats.
    Sado Y; Naito I; Okigaki T
    J Pathol; 1989 Aug; 158(4):325-32. PubMed ID: 2769491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G; Noble B; Van Liew J; Brentjens JR; Andres G
    J Immunol; 1986 Mar; 136(6):2127-35. PubMed ID: 3485141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats.
    Natorio Y; Hayakawa I; Shibata S
    Am J Pathol; 1989 Feb; 134(2):405-10. PubMed ID: 2563637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen.
    Singh AK; Schwartz MM
    Immunology; 1986 Nov; 59(3):451-8. PubMed ID: 3539772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A nephropathy induced by immunization of rats with EHS tumour.
    Kazama T; Nakamura T; Morioka T; Oite T; Sato Y; Shimizu F
    Clin Exp Immunol; 1985 Oct; 62(1):104-11. PubMed ID: 3905093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In situ immune complex formation in isolated perfused kidney using homologous antibody.
    Makker SP; Moorthy B
    Lab Invest; 1981 Jan; 44(1):1-5. PubMed ID: 6450297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Purification and characterization of human nephritogenic antigen that induces anti-GBM nephritis in rats.
    Sado Y; Kagawa M; Kishiro Y; Naito I; Joh K; Ninomiya Y
    J Pathol; 1997 Jun; 182(2):225-32. PubMed ID: 9274535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute effect of passive Heymann nephritis on renal blood flow and glomerular filtration rate in the rat: role of the anaphylatoxin C5a and the alpha-adrenergic nervous system.
    Sekse I; Iversen BM; Daha MR; Ofstad J
    Nephron; 1992; 60(4):453-9. PubMed ID: 1316560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of evidence for a role of renal tubular antigen in human membranous glomerulonephritis.
    Collins AB; Andres GA; McCluskey RT
    Nephron; 1981; 27(6):297-301. PubMed ID: 7022245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.